# US 2021/0332087 A1 · Vaccines and vaccine components for inhibition of microbial cells

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332087 A1
- Document ID: US20210332087A1
- Status: Published application
- Kind: A1
- Application number: 17/226,028
- Filed: 2021-04-08
- Published: 2021-10-28
- Earliest claimed: 2007-09-25
- Assignees: Pastoral Greenhouse Gas Research Limited
- Applicants: Pastoral Greenhouse Gas Research Limited
- Inventors: Eric Heinz ALTERMANN; Graeme Trevor ATTWOOD; Dong LI; William John KELLY; Zhanhao KONG; Sinead Christine LEAHY
- Web page: https://patentgrep.com/patent/US20210332087A1

## CPC

- C07K 14/005: from viruses
- A61P 1/00: Drugs for disorders of the alimentary tract or the digestive system
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P 31/04: Antibacterial agents
- A61P 37/04: Immunostimulants
- C12N 1/20: Bacteria; Culture media therefor
- C12N 7/00: Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof (preparing medicinal viral antigen or antibody compositions, e.g. virus vaccines, A61K39/00)
- C12N 9/641: {Cysteine endopeptidases (3.4.22)}
- A61K 35/13: Tumour cells, irrespective of tissue of origin (tumour vaccines A61K39/00)
- C07K 2319/00: Fusion polypeptide
- C12N 2795/10021: Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C12N 2795/10022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- Y02P 60/22: Methane [CH4], e.g. from rice paddies
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The invention encompasses components from microbial cells which are useful for antibody production, including peptides, polypeptides comprising these peptides, polynucleotides which encode these peptides or polypeptides, and antibodies directed to these peptides, polypeptides, or polynucleotides. The invention also encompasses to expression vectors and host cells for producing these peptides, polypeptides, polynucleotides, and antibodies. The invention further encompasses methods and compositions, especially vaccine compositions, for detecting, targeting, and inhibiting microbial cells, especially methanogen cells, using one or more of the disclosed peptides, polypeptides, polynucleotides, antibodies, expression vectors, and host cells.

## Claims

### Claim at position 1

1-62. (canceled)

### Claim 63

A vaccine composition comprising a polypeptide comprising the amino acid sequence of SEQ ID NO: 429, and an adjuvant.

### Claim 64 (depends on 63)

The vaccine composition of claim 63, wherein the polypeptide comprises a conjugate or fusion molecule.

### Claim 65 (depends on 63)

A kit for reducing methanogen growth or methane production in a ruminant comprising a vaccine composition of claim 63.

### Claim 66 (depends on 63)

A method of vaccinating an animal against a methanogen, comprising administering to said animal, a vaccine composition according to claim 63.

### Claim 67 (depends on 66)

The method of claim 66, wherein the methanogen is Methanobrevibacter ruminantium.

### Claim 68 (depends on 66)

The method of claim 66, wherein the animal is a ruminant.

### Claim 69 (depends on 66)

The method of claim 66, wherein the ruminant is selected from the group consisting of cattle, sheep, goats, buffalo, moose, antelope, caribou, and deer.

### Claim 70 (depends on 66)

A method of reducing methane emissions from a ruminant, comprising vaccinating the ruminant against a methanogen according to claim 66.
